Page 5 - Markl Baum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Markl baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Markl Baum Today - Breaking & Trending Today

Harrow Health, Inc. (NASDAQ:HROW) Shares Sold by Mendota Financial Group LLC

Mendota Financial Group LLC lowered its holdings in shares of Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 4.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,073 shares of the company’s stock after selling 884 shares during the […] ....

Martina Makary , Markl Baum , Surface Ophthalmics Inc , Advisor Alliance , Mendota Financial Group , News Ratings For Harrow Health Daily , Exchange Commission , Harrow Health Inc , Clarivest Asset Management , Silver Oak Securities Incorporated , Harrow Health Profile , Eton Pharmaceuticals Inc , Pharmaceuticals Inc , Harrow Health Trading Down , Harrow Health , Capital Management , Quarter For Harrow Health , Free Report , Financial Group , Oak Securities Incorporated , Vest Asset Management , Independent Advisor Alliance , Health Trading Down , Get Free Report , Director Martin , Surface Ophthalmics ,

Westside Investment Management Inc. Lowers Stock Position in Harrow Health, Inc. (NASDAQ:HROW)

Westside Investment Management Inc. reduced its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 11.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 133,744 shares of the company’s stock after selling 16,865 shares during the quarter. Westside Investment […] ....

Markl Baum , Zurcher Kantonalbank Zurich Cantonalbank , Pharmaceuticals Inc , News Ratings For Harrow Health Daily , Harrow Health , Quarter For Harrow Health , Harrow Health Company Profile , Westside Investment Management Inc , Harrow Health Inc , Exchange Commission , Securities Exchange Commission , Harrow Health Stock , Mendota Financial Group , Insider Activity At Harrow Health , Marshall Wace , Eton Pharmaceuticals Inc , Jump Financial , Surface Ophthalmics Inc , Opaleye Management Inc , Westside Investment Management , Free Report , Investment Management , Financial Group , Opaleye Management , Get Free Report , Surface Ophthalmics ,

Harrow Health, Inc. (NASDAQ:HROW) Position Trimmed by Invictus Private Wealth LLC

Invictus Private Wealth LLC lowered its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 17.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 639,316 shares of the company’s stock after selling 134,806 shares during the period. Harrow Health makes up about 1.6% […] ....

Markl Baum , Martina Makary , Zurcher Kantonalbank Zurich Cantonalbank , Securities Exchange Commission , Quarter For Harrow Health , News Ratings For Harrow Health Daily , Pharmaceuticals Inc , Marshall Wace , Eton Pharmaceuticals Inc , Mendota Financial Group , Harrow Health , Insider Transactions At Harrow Health , Surface Ophthalmics Inc , Invictus Private Wealth , Harrow Health Stock Down , Jump Financial , Harrow Health Company Profile , Harrow Health Inc , Free Report , Private Wealth , Financial Group , Director Martin , Exchange Commission , Health Stock Down , Get Free Report , Surface Ophthalmics ,

Harrow Health (NASDAQ:HROW) Trading 6.5% Higher

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report)’s share price was up 6.5% during trading on Monday . The stock traded as high as $15.89 and last traded at $15.80. Approximately 191,766 shares were traded during trading, a decline of 58% from the average daily volume of 455,751 shares. The stock had previously closed at […] ....

Markl Baum , Martina Makary , Wasatch Advisors Inc , Harrow Health , Surface Ophthalmics Inc , Harrow Health Company Profile , Hedge Funds Weigh In On Harrow Health , Blackrock Inc , Harrow Health Inc , Envestnet Asset Management Inc , News Ratings For Harrow Health Daily , Prelude Capital Management , Eton Pharmaceuticals Inc , Harrow Health Price Performance , Pharmaceuticals Inc , Get Free Report , Director Martin , Asset Management , Capital Management , State Street Corp , Street Corp , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow ,

Mark L. Baum Purchases 5,800 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stock

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 5,800 shares of the company’s stock in a transaction that occurred on Monday, August 14th. The shares were acquired at an average price of $17.05 per share, with a total value of $98,890.00. Following the completion of the transaction, the chief executive […] ....

Markl Baum , News Ratings For Harrow Health Daily , Harrow Health Inc , Surface Ophthalmics Inc , Harrow Health , Securities Exchange Commission , Pharmaceuticals Inc , Capital Management , Eton Pharmaceuticals Inc , Blackrock Inc , Harrow Health Stock Performance , Portolan Capital Management , Get Free Report , Exchange Commission , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Insider Trading , Nsider Trades ,